Vitamin D levels in adults with newly diagnosed ITP
Part of Blood & lymphatic clinical trials.
This study looks at vitamin D levels in adults with newly diagnosed immune thrombocytopenia (ITP), a condition where your immune system attacks your platelets. It aims to see if low vitamin D might be related to how the disease responds to first-line steroid treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult, 18 years or older.
- You must have primary ITP (that means your low platelets are not caused by another disease).
- You must have received steroid treatment as your first line of therapy.
- You cannot have a chronic kidney disease or chronic liver disease.
- You cannot be on second-line steroid treatment or have malnutrition issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood and immune system patterns in adults with primary immune thrombocytopenia (ITP) who are starting their first treatment. The goal is to better understand what’s happening in ITP, which may improve how future patients are cared for.
This trial looks at whether certain proteins in the blood can help doctors diagnose immune thrombocytopenia (ITP), a condition where your immune system destroys platelets. It may help find a faster, simpler way to confirm ITP.
This study looks at how people with immune thrombocytopenia (ITP) are treated in real life. It aims to understand which treatments work best for patients who have had ITP for up to 12 months.
This trial tests a new drug called PN20 for adults with a long-term low platelet condition called immune thrombocytopenia (ITP). It aims to see if the drug can safely raise platelet counts for people who have not gotten better with other treatments.
This study looks at whether having thyroid problems is common in people with ITP and if it affects how well ITP treatments work. By joining, you might help doctors understand this link and improve care for others.
This trial tests if a substance called NAD can help adults with immune thrombocytopenia (ITP) whose platelet levels stay low even after standard treatments. ITP is a condition where the immune system attacks platelets, causing easy bruising and bleeding. The study aims to see if NAD can safely raise platelet counts.
Hear when a new Vitamin D Concentration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.